External validation of the EFFECT mortality prediction scale in patients admitted for acute heart failure in Araba, Spain

S. Goya-Lirio , M. Hernando-Llorens , S. García de Garayo-Díaz , J. Regalado-de Los Cobos
{"title":"External validation of the EFFECT mortality prediction scale in patients admitted for acute heart failure in Araba, Spain","authors":"S. Goya-Lirio ,&nbsp;M. Hernando-Llorens ,&nbsp;S. García de Garayo-Díaz ,&nbsp;J. Regalado-de Los Cobos","doi":"10.1016/j.rceng.2024.05.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>To validate the EFFECT (Enhanced Feedback for Effective Cardiac Treatment) scales, which predict mortality at 1 month and 1 year after admission, in a defined cohort of patients admitted to the Araba University Hospital (HUA) with a diagnosis of acutely decompensated heart failure.</p></div><div><h3>Method</h3><p>External validation study of a predictive model, in a retrospective cohort of patients admitted between October 1, 2020 and September 30, 2021.</p></div><div><h3>Results</h3><p>A total of 550 patients were included. The two scales demonstrated good overall discriminatory ability in our series, with an area under ROC (0.755 y 0.756) and values in Brier score (0.094 y 0.194) similar to the original series. Calibration was assessed using the Hosmer-Lemeshow test and calibration plots and was also adequate. All this despite the fact that significant differences were observed in many clinical characteristics between our series and the original one.</p></div><div><h3>Conclusions</h3><p>The EFFECT scales showed good predictive ability and transportability. The one-month prediction scale was also useful for predicting mortality at one year. For both time periods, mortality was similar in the groups established in the original as low and very low risk.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 6","pages":"Pages 379-386"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2254887424000766","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

To validate the EFFECT (Enhanced Feedback for Effective Cardiac Treatment) scales, which predict mortality at 1 month and 1 year after admission, in a defined cohort of patients admitted to the Araba University Hospital (HUA) with a diagnosis of acutely decompensated heart failure.

Method

External validation study of a predictive model, in a retrospective cohort of patients admitted between October 1, 2020 and September 30, 2021.

Results

A total of 550 patients were included. The two scales demonstrated good overall discriminatory ability in our series, with an area under ROC (0.755 y 0.756) and values in Brier score (0.094 y 0.194) similar to the original series. Calibration was assessed using the Hosmer-Lemeshow test and calibration plots and was also adequate. All this despite the fact that significant differences were observed in many clinical characteristics between our series and the original one.

Conclusions

The EFFECT scales showed good predictive ability and transportability. The one-month prediction scale was also useful for predicting mortality at one year. For both time periods, mortality was similar in the groups established in the original as low and very low risk.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对西班牙阿拉巴地区急性心力衰竭住院患者的 EFFECT 死亡率预测量表进行外部验证。
目的:在阿拉巴大学医院(HUA)确诊为急性失代偿性心力衰竭的住院患者群体中验证EFFECT(有效心脏治疗强化反馈)量表,该量表可预测入院后1个月和1年的死亡率:方法:对2020年10月1日至2021年9月30日期间入院的患者进行回顾性队列研究,对预测模型进行外部验证:结果:共纳入 550 名患者。在我们的系列研究中,这两个量表表现出良好的整体判别能力,ROC下面积(0.755 y 0.756)和Brier评分值(0.094 y 0.194)与原始系列相似。使用 Hosmer-Lemeshow 检验和校准图对校准进行了评估,结果也是适当的。尽管在许多临床特征方面,我们的系列研究与原始系列研究之间存在着显著差异,但我们还是取得了上述成果:结论:EFFECT量表具有良好的预测能力和可移植性。结论:EFFECT量表显示出良好的预测能力和可移植性,一个月的预测量表对预测一年的死亡率也很有用。在这两个时间段内,在最初确定的低风险组和极低风险组中,死亡率相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2? The rights and interests of participants as limits to clinical trials. Artificial intelligence in clinical practice: Quality and evidence. Incidence of pregnancy related pulmonary embolism in Spain 2016-2021: an observational population-based retrospective study Soluble receptor for advanced glycation end-products positively correlated to kidney injury with coronary heart disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1